Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A P G Crijns

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Nederlands Tijdschrift Voor Geneeskunde|February 6, 2002
[Acute hepatitis after use of a herbal preparation with greater celandine (Chelidonium majus)]A P G Crijns, P A G M de Smet, M van den Heuvel, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 30, 2016
Radiation-induced fibrosis in the boost area after three-dimensional conformal radiotherapy with a simultaneous integrated boost technique for early-stage breast cancer: A multivariable prediction modelC Hammer, J H Maduro, E J Bantema-Joppe, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 7, 2006
Molecular prognostic markers in ovarian cancer: toward patient-tailored therapyA P G Crijns, E W Duiker, S de Jong, et al.
Journal of Medical Systems|March 26, 2022
Automatic Cardiac Structure Contouring for Small Datasets with Cascaded Deep Learning ModelsL B van den Oever, D S Spoor, A P G Crijns, et al.
Breast (Edinburgh, Scotland)|June 18, 2023
A comparison of cardiovascular and pulmonary morbidities and risk factors in breast cancer survivors compared to an age-matched female control group in the Lifelines prospective population cohortD S Spoor, V A B van den Bogaard, N M Sijtsema, et al.
British Journal of Cancer|June 11, 2009
Modest effect of p53, EGFR and HER-2/neu on prognosis in epithelial ovarian cancer: a meta-analysisP de Graeff, A P G Crijns, S de Jong, et al.
Breast (Edinburgh, Scotland)|April 10, 2026
Prevalence of cardiac dysfunction and longitudinal changes in cardiac function after breast cancer treatment with chemotherapy with/without radiation therapy compared with controlsL T van der Wal, S W M C Maass, M R de Boer, et al.
Clinical and Translational Radiation Oncology|November 17, 2022
Supraventricular cardiac conduction system exposure in breast cancer patients treated with radiotherapy and association with heart and cardiac chambers dosesM Y Errahmani, M Locquet, D Broggio, et al.
British Journal of Cancer|August 2, 2006
Factors influencing p53 expression in ovarian cancer as a biomarker of clinical outcome in multicentre studiesP de Graeff, J Hall, A P G Crijns, et al.
European Journal of Cancer (Oxford, England : 1990)|October 24, 2007
MEIS and PBX homeobox proteins in ovarian cancerA P G Crijns, P de Graeff, D Geerts, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Nederlands Tijdschrift Voor Geneeskunde|February 6, 2002
[Acute hepatitis after use of a herbal preparation with greater celandine (Chelidonium majus)]A P G Crijns, P A G M de Smet, M van den Heuvel, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 30, 2016
Radiation-induced fibrosis in the boost area after three-dimensional conformal radiotherapy with a simultaneous integrated boost technique for early-stage breast cancer: A multivariable prediction modelC Hammer, J H Maduro, E J Bantema-Joppe, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 7, 2006
Molecular prognostic markers in ovarian cancer: toward patient-tailored therapyA P G Crijns, E W Duiker, S de Jong, et al.
Journal of Medical Systems|March 26, 2022
Automatic Cardiac Structure Contouring for Small Datasets with Cascaded Deep Learning ModelsL B van den Oever, D S Spoor, A P G Crijns, et al.
Breast (Edinburgh, Scotland)|June 18, 2023
A comparison of cardiovascular and pulmonary morbidities and risk factors in breast cancer survivors compared to an age-matched female control group in the Lifelines prospective population cohortD S Spoor, V A B van den Bogaard, N M Sijtsema, et al.
British Journal of Cancer|June 11, 2009
Modest effect of p53, EGFR and HER-2/neu on prognosis in epithelial ovarian cancer: a meta-analysisP de Graeff, A P G Crijns, S de Jong, et al.
Breast (Edinburgh, Scotland)|April 10, 2026
Prevalence of cardiac dysfunction and longitudinal changes in cardiac function after breast cancer treatment with chemotherapy with/without radiation therapy compared with controlsL T van der Wal, S W M C Maass, M R de Boer, et al.
Clinical and Translational Radiation Oncology|November 17, 2022
Supraventricular cardiac conduction system exposure in breast cancer patients treated with radiotherapy and association with heart and cardiac chambers dosesM Y Errahmani, M Locquet, D Broggio, et al.
British Journal of Cancer|August 2, 2006
Factors influencing p53 expression in ovarian cancer as a biomarker of clinical outcome in multicentre studiesP de Graeff, J Hall, A P G Crijns, et al.
European Journal of Cancer (Oxford, England : 1990)|October 24, 2007
MEIS and PBX homeobox proteins in ovarian cancerA P G Crijns, P de Graeff, D Geerts, et al.
Pageof 2